Intraperitoneal aerosolization of @entity1341 is a safe and effective method in controlling XXXX in laparoscopic Roux-en-Y gastric bypass.

@entity1 @entity28 @entity1341 @entity158 @entity282
INTRODUCTION: @entity28 is a worldwide problem and has grown in severity in the last few decades making bariatric surgery and, in particular, laparoscopic banding and Roux-en-Y gastric bypass efficacious and cost-effective procedures. The laparoscopic approach has been shown to offer significant healthcare benefits, of particular interests are reports of @entity282 resulting in a shorter hospital stay and an earlier return to normal activity. However, many @entity1 still experience significant @entity158 , including shoulder @entity158 , that require strong analgesia including opiates during their early recovery period. The aims of this study were to establish the safe use of the aerosolization technique in bariatric surgery and to investigate the possible benefits in reducing @entity282 . METHODS: In this study, fifty @entity1 undergoing laparoscopic gastric bypass were recruited and divided into two groups; control (n = 25) and therapeutic (n = 25). The control group received intraperitoneal aerosolization of 10 mL of 0.9% normal saline while the therapeutic group received 10 mL of 0.5% @entity1341 . All the @entity1 had standard preoperative, intraoperative, and postoperative care. @entity158 scores were carried out by the nursing staff in recovery and 6 h, 12 h and 24 h postoperatively using a standard 0-10 @entity158 scoring scale. In addition, opiate consumption via @entity1 -controlled analgesia (PCA) was recorded. RESULTS: Aerosolized @entity1341 reduced @entity282 in comparison to normal saline (p < 0.05). However, PCA usage showed no statistically significant change from the control group. CONCLUSION: The aims of this study were achieved and we were able to establish the safe use of the aerosolization technique in bariatric surgery and its benefits in reducing @entity282 .
